Both in Pharmaceuticals
XBiotech vs Gossamer Bio
Over the past year XBIT returned −13.1% and GOSS returned −95.1%; their daily moves had a correlation of -0.01.
XBIT −13.1% GOSS −95.1%Growth of $1, one year, split-adjusted
| Metric | XBIT | GOSS |
|---|---|---|
| Price | $1.99 | $9.28 |
| Market cap | $60.7M | $56.8M |
| Today | +3.65% | −1.80% |
| 1 month | −8.7% | −12.9% |
| 6 months | −22.0% | −65.5% |
| Year to date | −16.7% | −96.3% |
| 1 year | −15.3% | −95.3% |
| Revenue growth (YoY) | — | −19.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 182.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.1× |
| Net cash | $109.5M | $20.9M |
| Dividend yield | — | — |
| Volatility (60d) | 36.1% | 1,265.9% |
| Short % of float | 1.8% | 24.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).